7 December 2015 - Pfizer today announced that the U.S. FDA has approved QuilliChew ER chewable tablets. Pfizer now offers two different products for the treatment of ADHD in patients ages 6 years old and above – liquid Quillivant XR (methylphenidate HCl) CII and new QuilliChew ER chewable tablets.

For more details, go to: http://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_u_s_fda_approval_of_new_quillichew_er_methylphenidate_hydrochloride_extended_release_chewable_tablets_cii